BEUDAMED
    FDA Adverse Event Injury Summary report: N

    CHROMATOGRAPHY (THIN LAYER) CLINICAL USE - AMTOX DRUG DETECTION SYSTEM

    MDR report key: 7533988 · Received May 21, 2018

    Report

    Report Number
    MW5077373
    Event Type
    Injury
    Date Received
    May 21, 2018
    Date of Event
    February 21, 2018
    Report Date
    May 20, 2018
    Manufacturer
    AMERITOX
    Product Code
    DJC
    Adverse Event
    Yes
    Product Problem
    Yes
    Report Source
    Voluntary report
    Reporter Location
    MS, US
    Reporter Occupation
    PATIENT

    Narratives

    Description of Event or Problem · 1

    I WAS AT A ROUTINE PHYSICIAN VISIT WHEN ASK IF I WOULD TAKE THE DRUG SCREEN BECAUSE OF A NEW REGULATION BEING IMPLEMENTED. I DID. THEN I WAS TOLD THAT I FAILED THE TEST FOR METHAMPHETAMINE AND WAS DENIED PRESCRIPTIONS FOR XANAX, ALTHOUGH I WAS ADVISED NOT TO ABRUPTLY STOP TAKING THEM, WAS NOT REFERRED TO ANOTHER PHYSICIAN. I TOLD THEM THAT THE TEST WAS WRONG, AS I HAD NOTHING IN MY SYSTEM OTHER THAN PRESCRIBED MEDICATIONS BUT WAS TOLD THAT I COULD NOT RETAKE THE TEST AND NOTHING COULD BE DONE.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    371659 CHROMATOGRAPHY (THIN LAYER) CLINICAL USE - AMTOX DRUG DETECTION SYSTEM CHROMATOGRAPHY (THIN LAYER) CLINICAL USE - AMTOX DRUG DETECTION SYSTEM DJC AMERITOX

    Patients

    Seq Age Sex Outcome Treatment
    1 Disability